Mark M. Goodman
Affiliations: | Emory University, Atlanta, GA |
Area:
Medicinal ChemistryWebsite:
http://www.yerkes.emory.edu/research/divisions/neuropharmacology_neurologic_diseases/goodman_mark.htmlGoogle:
"Mark Goodman"Mean distance: 9.98 (cluster 15) | S | N | B | C | P |
Parents
Sign in to add mentor| William W. Paudler | grad student | University of Alabama | |
| David R. Elmaleh | post-doc | Harvard (Neurotree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Pickel TC, Pashikanti G, Voll RJ, et al. (2021) Synthesis, Radiolabeling, and Biological Evaluation of the -Stereoisomers of 1-Amino-3-(fluoro-F)-4-fluorocyclopentane-1-carboxylic Acid as PET Imaging Agents. Acs Pharmacology & Translational Science. 4: 1195-1203 |
| Pickel T, Voll RJ, Yu W, et al. (2020) Synthesis, Radiolabeling, and Biological Evaluation of the Cis Stereoisomers of 1-amino-3-(fluoro-18F)-4-fluorocyclopentane-1-carboxylic acid as PET Imaging Agents. Journal of Medicinal Chemistry |
| Stehouwer JS, Birnbaum MS, Voll RJ, et al. (2020) Erratum to "Synthesis, F-18 radiolabeling, and microPET evaluation of 3-(2,4-dichlorophenyl)-N-alkyl-N-fluoroalkyl-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-amines as ligands of the corticotropin-releasing factor type-1 (CRF1) receptor" [Bioorg. Med. Chem. 23 (2015) 4286-4302]. Bioorganic & Medicinal Chemistry. 115660 |
| Alemozaffar M, Akintayo AA, Abiodun-Ojo OA, et al. (2020) [F]fluciclovine PET/CT for Preoperative Staging in Patients with Intermediate to High-Risk Primary Prostate Cancer. The Journal of Urology. 101097JU000000000000 |
| Oum YH, Shetty D, Yoon Y, et al. (2019) A benzenesulfonamide derivative as a novel PET radioligand for CXCR4. Bioorganic & Medicinal Chemistry. 115240 |
| Abiodun-Ojo OA, Akintayo AA, Akin-Akintayo OO, et al. (2019) F-Fluciclovine parameters on targeted prostate biopsy associated with true positivity in recurrent prostate cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine |
| Fei B, Abiodun-Ojo OA, Akintayo AA, et al. (2019) Feasibility and Initial Results: Fluciclovine PET/Ultrasound Fusion Targeted Biopsy of Recurrent Prostate Cancer. The Journal of Urology. 101097JU000000000000 |
| Parent EE, Benayoun M, Ibeanu I, et al. (2018) [F]Fluciclovine PET discrimination between high- and low-grade gliomas. Ejnmmi Research. 8: 67 |
| Tade FI, Wiles WG, Lu G, et al. (2018) Selective modification of fluciclovine (F) transport in prostate carcinoma xenografts. Amino Acids |
| Akin-Akintayo O, Tade F, Mittal P, et al. (2018) Prospective evaluation of fluciclovine (F) PET-CT and MRI in detection of recurrent prostate cancer in non-prostatectomy patients. European Journal of Radiology. 102: 1-8 |